FDA Inspection 950797 — Mclaughlin Gormley King Company
The FDA completed an inspection of Mclaughlin Gormley King Company on Nov 12, 2015 in Chaska, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 12, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chaska, MN (United States)